Biomx Ltd (PHGE) Stock Price, Quote & News

Company Profile

BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies. The company's portfolio targets various niches, such as counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting. It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers. The company was founded in 2015 and is based in Dover, Delaware.

Industry: Aerospace & Defense

Sector: Industrials

Website: www.biomx.com

Address:

850 New Burton Road, Suite 201, Dover, United States

TWITLIEDETECTOR Jul. 4 at 2:52 AM

$PHGE is this company now an israeli drone company? been reading up on this. suppose to be a booming market for this in that part of the world

0 · Reply

toffernelson Jul. 3 at 2:23 PM

$PHGE I’m still in this. Need to catch up on the last six weeks of news.

1 · Reply

TWITLIEDETECTOR Jul. 2 at 4:02 PM

$PHGE this could still lose support. put in a starting buy at .31

0 · Reply

wowwwwww2 Jul. 2 at 1:54 PM

$PHGE 10k shares at .33

0 · Reply

Maximusprime22 Jul. 1 at 10:15 PM

$PHGE all warrants seem to have been mostly converted to shares by this point if not all from before the run from .40 to 2. So dilution has run its course this has to be very close to the bottom. Yes the float has risen from around 1 million outstanding to around 11 that is still a small amount. Many more big time days seem to be on the horizon as long as they manage the transition well from here.

0 · Reply

Maximusprime22 Jul. 1 at 10:07 PM

$PHGE + 10,000 something has to give and soon!

0 · Reply

VXRT007 Jul. 1 at 5:54 PM

$PHGE Seems like it should hold. Going to wait a little longer. Good news should pop this over $!.00

0 · Reply

flatman77 Jul. 1 at 2:46 PM

$PHGE BY EOD $2+

1 · Reply

wowwwwww2 Jul. 1 at 1:52 PM

$PHGE who's still selling down here smh

0 · Reply

TWITLIEDETECTOR Jul. 1 at 4:59 AM

$PHGE .30 is the 1 month low 13 week low and 52 week low

0 · Reply

BiomX files to sell 7.16M shares of common stock for holders

Jun 29, 2026, 8:00 AM EDT - 5 days ago

BiomX Registration statement: Registration filing

Jun 24, 2026, 8:38 AM EDT - 10 days ago

BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026

Jun 22, 2026, 8:00 AM EDT - 12 days ago

BiomX Proxy statement: Proxy filing

Jun 18, 2026, 9:15 AM EDT - 16 days ago

BiomX Provides Update on Defense Technology Portfolio and Growth Strategy

Jun 15, 2026, 7:00 AM EDT - 19 days ago

BiomX Slides: Investor presentation

2026-06-12T13:16:16.000Z - 22 days ago

BiomX announces acceptance of plan to regain compliance with NYSE

Jun 12, 2026, 9:00 AM EDT - 22 days ago

BiomX Announces NYSE American Acceptance of Plan to Regain Compliance

Jun 11, 2026, 9:03 AM EDT - 23 days ago

BiomX: Zorronet's AI Security Experts Provide In-Depth Review on Why Security AI Must Move Beyond Detection to Understanding in High-Stakes Global Events

Jun 8, 2026, 8:00 AM EDT - 26 days ago

BiomX Proxy statement: Proxy filing

2026-06-02T13:56:30.000Z - 4 weeks ago

BiomX appoints Gabby Sarusi as strategic advisor

Jun 2, 2026, 9:32 AM EDT - 4 weeks ago

Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit

Jun 1, 2026, 9:25 AM EDT - 4 weeks ago

Zorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud Dependence

2026-05-27T15:22:44.000Z - 5 weeks ago

BiomX names Roy Timor-Rousso as Chief Business Officer

May 27, 2026, 9:40 AM EDT - 5 weeks ago

BiomX Appoints IDF Colonel (res.) Roy Timor-Rousso as Chief Business Officer to Strengthen Defense & Security Operations

May 20, 2026, 4:00 PM EDT - 6 weeks ago

BiomX Quarterly report: Q1 2026

May 6, 2026, 4:15 PM EDT - 2 months ago

BiomX's Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand

Apr 16, 2026, 4:30 PM EDT - 2 months ago

Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems

Apr 13, 2026, 9:20 AM EDT - 2 months ago

BiomX Accelerates Defense Technology Buildout with DFSL Acquisition

Apr 10, 2026, 8:30 AM EDT - 3 months ago

BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications

2026-04-09T18:36:16.000Z - 3 months ago

Biomx Inc trading halted, news pending

2026-04-01T14:10:15.000Z - 3 months ago

Biomx Inc trading resumes

2026-04-01T13:38:15.000Z - 3 months ago

Biomx Inc trading halted, news pending

Mar 31, 2026, 10:48 AM EDT - 3 months ago

BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System

Mar 30, 2026, 9:28 AM EDT - 3 months ago

BiomX Adds Former Mossad Deputy to Advisory Board

2026-03-27T20:40:15.000Z - 3 months ago

BiomX receives noncompliance notification from Nasdaq

Mar 27, 2026, 4:30 PM EDT - 3 months ago

BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency

2026-03-26T13:08:14.000Z - 3 months ago

BiomX launches X Security & Defense subsidiary in Israel

Mar 26, 2026, 8:48 AM EDT - 3 months ago

BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations

Mar 25, 2026, 8:00 AM EDT - 3 months ago

BiomX Proxy statement: Proxy filing

2026-03-19T13:20:44.000Z - 3 months ago

BiomX issues letter to shareholders

Mar 19, 2026, 9:15 AM EDT - 3 months ago

BiomX CEO Issues Letter to Stockholders

Mar 11, 2026, 8:00 AM EDT - 4 months ago

BiomX Transcript: EGM 2026

2026-03-09T14:55:29.000Z - 4 months ago

BiomX downgraded to Neutral from Buy at H.C. Wainwright

2026-03-09T13:07:20.000Z - 4 months ago

BiomX names Michael Oster as CEO, David Rokach as CFO

Mar 9, 2026, 9:00 AM EDT - 4 months ago

BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth

2026-03-05T16:00:36.000Z - 4 months ago

Biomx Inc trading resumes

2026-03-05T15:55:32.000Z - 4 months ago

Biomx Inc trading halted, volatility trading pause

Feb 25, 2026, 8:00 AM EST - 4 months ago

BiomX Transcript: EGM 2026

Feb 19, 2026, 7:00 AM EST - 4 months ago

BiomX Annual report: Q4 2025

Feb 13, 2026, 7:00 AM EST - 5 months ago

BiomX Proxy statement: Proxy Filing

2026-02-09T21:40:33.000Z - 5 months ago

BiomX files to sell 5.31M shares of common stock for holders

Feb 9, 2026, 7:00 AM EST - 5 months ago

BiomX Registration statement: Registration Filing

Feb 3, 2026, 7:00 AM EST - 5 months ago

BiomX Proxy statement: Proxy Filing

2026-01-29T14:50:55.000Z - 5 months ago

Biomx Inc trading resumes

2026-01-29T14:46:29.000Z - 5 months ago

Biomx Inc trading halted, volatility trading pause

Jan 27, 2026, 1:41 PM EST - 5 months ago

BiomX Issues Statement Regarding Recent Common Stock Trading Activity

2025-12-29T13:15:13.000Z - 6 months ago

BiomX announces $3M private placement

Dec 29, 2025, 8:00 AM EST - 6 months ago

BiomX Announces $3.0 Million Private Placement

Nov 25, 2025, 4:40 PM EST - 7 months ago

BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis

Nov 12, 2025, 8:30 AM EST - 8 months ago

BiomX Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:30 AM EST - 8 months ago

BiomX Quarterly report: Q3 2025

Nov 12, 2025, 8:30 AM EST - 8 months ago

BiomX Earnings release: Q3 2025

Nov 12, 2025, 7:30 AM EST - 8 months ago

BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates

Oct 17, 2025, 8:30 AM EDT - 9 months ago

BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways

Aug 28, 2025, 8:00 AM EDT - 11 months ago

BiomX Proxy statement: Proxy Filing

Aug 28, 2025, 8:00 AM EDT - 11 months ago

BiomX Proxy statement: Proxy Filing

Aug 19, 2025, 8:19 AM EDT - 11 months ago

BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis

Aug 15, 2025, 8:00 AM EDT - 11 months ago

BiomX Proxy statement: Proxy Filing

Aug 13, 2025, 8:00 AM EDT - 11 months ago

BiomX Earnings Call Transcript: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 11 months ago

BiomX Quarterly report: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 11 months ago

BiomX Earnings release: Q2 2025

Aug 13, 2025, 6:30 AM EDT - 11 months ago

BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates

Aug 6, 2025, 8:30 AM EDT - 11 months ago

BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025

Jul 14, 2025, 9:00 AM EDT - 1 year ago

BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis

Jul 8, 2025, 8:30 AM EDT - 1 year ago

BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis

May 19, 2025, 10:02 AM EDT - 1 year ago

BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

May 15, 2025, 2:00 PM EDT - 1 year ago

BiomX Earnings Call Transcript: Q1 2025

May 15, 2025, 2:00 PM EDT - 1 year ago

BiomX Quarterly report: Q1 2025

May 15, 2025, 2:00 PM EDT - 1 year ago

BiomX Earnings release: Q1 2025

May 15, 2025, 6:30 AM EDT - 1 year ago

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates

May 8, 2025, 7:00 AM EDT - 1 year ago

BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

Apr 17, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

BiomX Registration statement: Registration Filing

Apr 3, 2025, 11:00 AM EDT - 1 year ago

BiomX Transcript: KOL Event

Apr 1, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

Apr 1, 2025, 6:30 AM EDT - 1 year ago

BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Earnings Call Transcript: Q4 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Annual report: Q4 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Earnings release: Q4 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Slides: Q4 2024

Mar 31, 2025, 6:30 AM EDT - 1 year ago

BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)

Mar 27, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

Mar 25, 2025, 6:30 AM EDT - 1 year ago

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates

Mar 19, 2025, 12:35 PM EDT - 1 year ago

BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Mar 17, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

Nov 14, 2024, 8:00 AM EST - 1 year ago

BiomX Earnings Call Transcript: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BiomX Quarterly report: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BiomX Earnings release: Q3 2024

Nov 14, 2024, 6:30 AM EST - 1 year ago

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates

Nov 12, 2024, 12:20 PM EST - 1 year ago

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024

Oct 15, 2024, 7:00 AM EDT - 1 year ago

BiomX Announces a Mandatory Unit Separation

Sep 18, 2024, 8:00 AM EDT - 1 year ago

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference

Sep 9, 2024, 7:00 AM EDT - 1 year ago

BiomX Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 4, 2024, 8:00 AM EDT - 1 year ago

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 16, 2024, 10:55 AM EDT - 2 years ago

UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 15, 2024, 8:00 AM EDT - 2 years ago

BiomX Earnings Call Transcript: Q2 2024

Aug 15, 2024, 8:00 AM EDT - 2 years ago

BiomX Quarterly report: Q2 2024

Aug 15, 2024, 8:00 AM EDT - 2 years ago

BiomX Earnings release: Q2 2024

Aug 15, 2024, 6:30 AM EDT - 2 years ago

BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 15, 2024, 6:30 AM EDT - 2 years ago

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates

Aug 8, 2024, 7:00 AM EDT - 2 years ago

BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024

Jul 29, 2024, 7:00 AM EDT - 2 years ago

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Jul 11, 2024, 8:00 AM EDT - 2 years ago

BiomX Registration statement: Registration Filing

Jul 10, 2024, 6:30 AM EDT - 2 years ago

BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock

Jul 9, 2024, 8:00 AM EDT - 2 years ago

BiomX Registration statement: Registration Filing

Jun 17, 2024, 8:00 AM EDT - 2 years ago

BiomX Proxy statement: Proxy Filing

Jun 13, 2024, 8:00 AM EDT - 2 years ago

BiomX Proxy statement: Proxy Filing

May 30, 2024, 4:50 PM EDT - 2 years ago

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

May 30, 2024, 7:00 AM EDT - 2 years ago

BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024

May 28, 2024, 8:00 AM EDT - 2 years ago

BiomX Proxy statement: Proxy Filing

May 21, 2024, 8:00 AM EDT - 2 years ago

BiomX Earnings Call Transcript: Q1 2024

May 21, 2024, 8:00 AM EDT - 2 years ago

BiomX Earnings release: Q1 2024

May 21, 2024, 8:00 AM EDT - 2 years ago

BiomX Quarterly report: Q1 2024

May 21, 2024, 6:30 AM EDT - 2 years ago

BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates

May 15, 2024, 7:00 AM EDT - 2 years ago

BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024

Apr 29, 2024, 8:00 AM EDT - 2 years ago

BiomX Registration statement: Registration Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

TWITLIEDETECTOR Jul. 4 at 2:52 AM

$PHGE is this company now an israeli drone company? been reading up on this. suppose to be a booming market for this in that part of the world

0 · Reply

toffernelson Jul. 3 at 2:23 PM

$PHGE I’m still in this. Need to catch up on the last six weeks of news.

1 · Reply

TWITLIEDETECTOR Jul. 2 at 4:02 PM

$PHGE this could still lose support. put in a starting buy at .31

0 · Reply

wowwwwww2 Jul. 2 at 1:54 PM

$PHGE 10k shares at .33

0 · Reply

Maximusprime22 Jul. 1 at 10:15 PM

0 · Reply

Maximusprime22 Jul. 1 at 10:07 PM

$PHGE + 10,000 something has to give and soon!

0 · Reply

VXRT007 Jul. 1 at 5:54 PM

$PHGE Seems like it should hold. Going to wait a little longer. Good news should pop this over $!.00

0 · Reply

flatman77 Jul. 1 at 2:46 PM

$PHGE BY EOD $2+

1 · Reply

wowwwwww2 Jul. 1 at 1:52 PM

$PHGE who's still selling down here smh

0 · Reply

TWITLIEDETECTOR Jul. 1 at 4:59 AM

$PHGE .30 is the 1 month low 13 week low and 52 week low

0 · Reply

TWITLIEDETECTOR Jun. 30 at 5:31 AM

$PHGE i suspect the bottom to be around .25

1 · Reply

jctataio Jun. 30 at 2:21 AM

$PHGE note at $12.00??? Wowew

0 · Reply

DonCorleone77 Jun. 30 at 12:27 AM

$AVAV $BTCT.X $GANX $PHGE $TW AFTER-HOURS MOVERS: Currently Higher After Earnings: - AeroVironment (AVAV) up 20.8% Currently Also Higher: - BTC Digital (BTCT) up 106.5% after announcing a $28M private placement - Gain Therapeutics (GANX) up 13.7% after receiving FDA clearance of its GT-02287 IND application - BiomX (PHGE) up 5.0% after filing to sell 7.16M shares of common stock for holders - Tradeweb (TW) up 1.7% after Goldman Sachs upgraded the stock to Buy from Neutral Currently Lower After Earnings: - Concentrix (CNXC) down 22.3% Currently Also Lower: - GMEX Robotics (GMEX) down 29.1% after announcing a 1-for-9 share consolidation - Nuvectis (NVCT) down 19.0% after announcing a common stock offering - Mama's Creations (MAMA) down 12.3% after announcing a common stock offering

0 · Reply

forsiz1 Jun. 29 at 10:22 PM

$PHGE One dollar by Friday again?

0 · Reply

Bigtimebigshot77 Jun. 29 at 10:14 PM

$PHGE hey remember. Neil said this was a lock. Lmao. 🤡

0 · Reply

Paulus1930 Jun. 29 at 7:42 PM

$PHGE is this heading for zero?

0 · Reply

thedavidsonny Jun. 29 at 7:27 PM

$LGCL 🔥 $NIVF 🔥 $THH 🔥 $RCT 🔥 $CIIT 🔥 $PHGE 🔥 AFTER-HOURS 💎 💎 💎 💎 💎 💎

0 · Reply

kotic Jun. 29 at 2:40 PM

$PHGE round 2 incoming

0 · Reply

TALENT_ON_LOAN_FROM_GOD Jun. 29 at 1:13 PM

$PHGE 11M????

0 · Reply

TALENT_ON_LOAN_FROM_GOD Jun. 29 at 1:04 PM

$PHGE I agree let’s roll

1 · Reply

Maximusprime22 Jun. 29 at 12:56 PM

$PHGE please don’t use this to put money you can’t afford to lose in this ticker I could be dead wrong.

0 · Reply

Maximusprime22 Jun. 29 at 12:56 PM

$PHGE back in at .371 think this could be a bigger and better run up If the act SI is where I think it is, borrow rate will cross over 800% I think another massive boom is coming. Last boom it tracked up 40% before getting offered on ( I assume that’s what happened) and with in a hour it was back at the days high. History doesn’t repeat it just gives sound advice. There is also still some news catalyst that could drop here any day or in the coming weeks. So fingers crossed on this reentry🤞🤞🤞

0 · Reply

Market Cap	3.76M
Revenue (ttm)	0.00
Net Income (ttm)	-36.20M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	396,200
Avg Vol	7,945,390
Day's Range	N/A - N/A
Shares Out	11.80M
Stochastic %K	9%
Beta	1.30
Analysts	Hold
Price Target	$26.00